Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.

Noronha V, Menon N, Shah M, Patil V, Dhanawat A, Prakash G, Pal M, Arora A, Misra A, Goud S, More S, Yadav A, Murthy V, Maitre P, Menon S, Popat P, Sable N, Agarwal A, Rangarajan V, Shetake A, Badwe R, Prabhash K

Open source

DOI: 10.1093/jnci/djag288
Published: 2026 Aug 24
Container: Journal of the National Cancer Institute
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djag288,
  title = {Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.},
  author = {Noronha V and Menon N and Shah M and Patil V and Dhanawat A and Prakash G and Pal M and Arora A and Misra A and Goud S and More S and Yadav A and Murthy V and Maitre P and Menon S and Popat P and Sable N and Agarwal A and Rangarajan V and Shetake A and Badwe R and Prabhash K},
  year = {2026},
  journal = {Journal of the National Cancer Institute},
  doi = {10.1093/jnci/djag288},
  url = {https://doi.org/10.1093/jnci/djag288}
}

RIS

TY  - JOUR
TI  - Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.
AU  - Noronha V
AU  - Menon N
AU  - Shah M
AU  - Patil V
AU  - Dhanawat A
AU  - Prakash G
AU  - Pal M
AU  - Arora A
AU  - Misra A
AU  - Goud S
AU  - More S
AU  - Yadav A
AU  - Murthy V
AU  - Maitre P
AU  - Menon S
AU  - Popat P
AU  - Sable N
AU  - Agarwal A
AU  - Rangarajan V
AU  - Shetake A
AU  - Badwe R
AU  - Prabhash K
PY  - 2026
JO  - Journal of the National Cancer Institute
DO  - 10.1093/jnci/djag288
UR  - https://doi.org/10.1093/jnci/djag288
ER  -

APA

V, N., N, M., M, S., V, P., A, D., G, P., M, P., A, A., A, M., S, G., S, M., A, Y., V, M., P, M., S, M., P, P., N, S., A, A., V, R., A, S., R, B., & K, P. (2026). Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag288

Source records

pubmed · retrieved 2026-09-26T11:32:30.120Z